Recent Blog Posts

View Post: Tendon Ruptures – Symptoms, Causes and Treatment
4 Nov 2009
Factive (gemifloxacin mesylate); Levaquin (levofloxacin); Cipro XR and Proquin XR. The above listed antibiotics are used fro the treatment of various diseases like. bronchitis, chlamydia, bacterial infection, pneumonia, urinary tract or ...
View Blog: rogersarkansasattorneys.com - http://www.rogersarkansasattorneys.com/

---

View Post: S.1616: United States-China Market Engagement and Export Promotion ...
5 Aug 2009 by opencongress.org  
S. 1617: A bill to suspend temporarily the duty on gemifloxacin, gemifloxacin mesylate, and gemifloxacin mesylate sesquihydrate. ... Source: Politics Daily. Did you find this article useful? Your opinion counts - together, we're finding ...
View Blog: Open Congress : Senate Banking, Housing,... - http://www.opencongress.org/committee/show/146_sena...

---

View Post: OSCIQ - Oscient Pharmaceuticals Corp (PINK Stock) - Stock Market ...
12 Aug 2009 by Volatile22  
The Company markets two products: ANTARA (fenofibrate) capsules, a cardiovascular product, and FACTIVE (gemifloxacin mesylate) tablets, a fluoroquinolone antibiotic. ANTARA is approved by the FDA to treat hypercholesterolemia (high ...
View Blog: Stock Market Forum, Penny Stocks, FOREX,... - http://www.stockmarketcats.com/

---

View Post: Sen. Ted Kennedy Dies -- Politics Daily
26 Aug 2009 by Patricia Murphy  
S. 1617: A bill to suspend temporarily the duty on gemifloxacin, gemifloxacin mesylate, and gemifloxacin mesylate sesquihydrate. Introduced Sep 6, 2005. S. 1749: Fair Wages for Hurricane Katrina Recovery Workers Act Introduced Sep 21, ...
View Blog: Politics Daily - http://www.politicsdaily.com/

---

View Post: gemifloxacin
27 Jun 2009 by Mlj  
new page: {{pharmacologybox ...
View Blog: gemifloxacin mesylate, factive^®}} as of june 2009 the application for emea centralised marketing authorisation was withdrawn by the manufacturer. [[ca... new page

---

View Post: Gemifloxacin-Associated Neurotoxicity Presenting as Encephalopathy ...
2 Apr 2009 by Barrett, M. J, Login, I. S  
Gemifloxacin mesylate is a fluoroquinolone approved in 2003 for treatment of mild-to-moderate community-acquired pneumonia and acute exacerbation of chronic bronchitis. Compared with other fluoroquinolones, gemifloxacin possesses ...
View Blog: Annals of Pharmacotherapy current issue - http://www.theannals.com/

---

View Post: Oscient Pharmaceuticals Corporation to Cut Sales Force - News ...
12 Jun 2009
Oscient Pharmaceuticals Corporation markets two FDA-approved products in the United States: ANTARA® (fenofibrate) capsules, a cardiovascular product and FACTIVE® (gemifloxacin mesylate) tablets, a fluoroquinolone antibiotic. ...
View Blog: BioSpace.com Featured News and Stories - http://www.biospace.com/

---